08/17/201 1 10:0 3 FA X 202493514 2 FA A 

## AUG . 16 , 201 1 5:0SP M REGULATOR Y AFFAIR S DM S JO . 24 ! @O01/02 3



### P . 1/2 3 

# • 4 Expres s FACSIMIL E TRANSMISSIO N SHEE T DATE : T O 8/36/201 1 TIME : 5;00p.m . CP T Federa l Aviatio n Administratio n TELECOPIE RNUMBER : FROM : 202-493-514 2 CYNTHI A A . CHANDLER-SNEL L Staf f Attorne y Lega l andRegulator

y Affair s FEDEX EXPRES S 362 0 Hack s Cros s Road Buildin g B-3'' * Floo r Memphis , T

N 3512 5 Phone:(901)434-836 ] Telecopier : (901 ) 434-828 3 

# 30 1 0-0?'/ I

I f yo u dono t

receiv e al l 2 3 page(s) , inclusiv e o f thi s cove r sheet , pleas e contac t m y Administrativ e Assistant , Tiffan y a t (901 ) 434-8576 , Message : TH E INFORMAnON CONTAINE D I N THI S FACSIMIL

E MESSAG

E IS ATTORNE

Y PRIVILEGE

D AN D CONFIDENTIA

L INFORMATIO

N INTENDE

D ONL Y FO RTH E US E O FTH E INDIVIDUA

L O RENITT Y NAME D ABOVE . E

FTH E READE RO FTHIS MESSAG

E I S NO T TH E INTENDE

D RECIPIENT , O

RTH E EMPLOYE

E O RAGEN T REPONSTBL

E T O DELIVE

RI T T O TH E INTENDE

D R£CIPIF^^: , YO U AR £HER E NOTIFIE D THA T AN Y DISSEMINATION , DISTRIBUTION , O R 

### COPYIN G O FTH E COMMUNICATIO N 

### IS STRICTL Y PROHIBFTED . I

FVO U HAV E RECEIVE

D THI S COMMUNICATIO N I N 

### ERROR , PLEAS E 

### IMMEDIATEL

Y NOTIF Y U S B Y TELEPHON

E AN D RETRU N TK E ORIGINA L

### MESSAG E T O U S A T TH EABOV E ADDDRESS .08/17/201 1 100 4 FAX 2024335U 2 FA A ^ OMS (2)002/02 3 

### AUG . 16 . 201 1 5 ; 09P M [ibGULATOS YAFFAIR S WO . 24 5 P . 2/2 5 

## Ji^PARTMEMTC F -\MSP0RWI0 N UNITE D STATE S O F

## AMERIC A . C;'-:i:

T OFERAllC'N

S DEPARTMEN T O FTRANSPORATIO N OFFIC E O FHEARING S WASHINGTON , D C 

### m i AU G 

### ! 1 P hO O 

### I n th e Matte r

o f FAA DOCKE T N O CP1ONMOO1 1 FEDERAL EXPRES S CORPORATIO N FAA CAS E N O 200SNM70012 7 I n the Matter

of FAA DOCKET N O CP l ONMO O 1 0 CORPORAT E AI

RFA A CAS E N O 2008NM70012 6 FEDEX AN D CORPORAT E AIR^ S RESPONS E T O FAA.^ S MOTIO N IN LIMINE AN D REQUES T FO REXTEOrTED RULIN G TH E HONORABLE RICHAR D C . GOODWI N COM E NO W th e Respondents , Federa l Expres s Corporatio n (hereinafter ^TedEx' O andCorporate Air , an di n respons e t o th e FAA' s Motio n i n Limin e an d Reques t fo r Expedite dRulin g submit s th e following : 1 . It i s admitte dtha

t FedEx , Corporate Air , an dth e FA A exchange ddiscovcrv ' o n th e agreed-upo n dal e o f Augus t 8 , 2011 , wherei n FedEx an dCorporat e Ai r name dBo

b Richarda s apoteatia l w-itness . 2 . I t i s admitte dtha

t Mr . Richardi s th e former Deputy

- Administrato r

for Hazardou s Material Safet y fo r th e Pipelin e an dHazardou s Material s Safet y Administratio n (PHN'ISA) . FedE x an dCorporate Ai r agre e that

ther e are requirement s governin g the matter s an dextent t o whic h Mr . Richardmay testify , whic h were addresse di n th e discover y response . FedE x an d Corporat e Ai r

di dno t nam e Mr . Richarda s a

n exper t or opinio n witoes s an d hav e n o intention s o f

usin g Mr . Richardi n an y manne r other than a s allowe d b y 4 0 CF.R. , Stibtitl e A , Par t 9 . Pag e 1 of 308/17/201 1 10.0 4 FA X 202493514 2 FA A- DM S 1^003/02 3 AUG . 16 . 201 ! 5:09P M REGULATOR Y AFFAIK S UO . 2=; O P . 3/2 3



### 3 . FedE x an dCorporat e Ai r respectfull y disa^^e e wit h th e interpretatio n o f th e F A A i n citin g th e Memorandu mattache da s a n exhibi t t o it s Motion , Whil e th e Memorandum , notabl y a n interpretatio n o f th e rule s b y aDO T auomey , clearl y addresse s tha t

aforme r

employe e i s no t

prohibite dfromtestifyin g abou t matter s tha t

h e di dno t

participat e i n o r

wi^r k o n w-hil e aDO T employee , th e Memorandu mdoe s no t impl y b y omissio n tha t al l testimon y abou t matter s aforme r

employe e di dparticipat e i n o r wor k o n is , conversely , prohibited . I n fact , suc h testimon y i s expressl y allowed , a s show n i n th e lette r

t o Mr . Richar dfromth e Deput y Chie f Counse l fo r PHMSA , 

### Sherr i Pappas , whic h th e FA A 

### include di n it s Supplemen t t o Motio n i n Limin e an dReque.' n fo r Expedite dHearin g filedAugus t 11 , 201 L 4 . Mr . Richar dreceive dpermissio n t o testif y vi aemai l o n Augus t 15 , 2011 , fromDeput y Chie f

Counse l Pappas , a s require dunde r 4 9 GF.R . 9.7(b) , pe r th e attache ddocument . 5 . Furthermore , FedE x an dCorporat e Ai r hav e cooperate dwit h th e Agenc y (PHMSA ) b y providin g alis t o f anticipate dquestion s t o ensur e tha t th e subjec t matte r an dinformatio n solicite ddoe s no t i n an y wa y expos e Mr . Richar dt o scrutin y unde r hi s post-employmen t

dtides , cithe r

unde r contrac t o r b y regulation . WHEREFORE , PREMISE S CONSIDERED , FedE x an dCorporat e Ai r respectfull y submi t

tha t th e FAA' s Motio n i n Limin e shoul db e denied , a s th e Agenc y Attorne y ha s provide dapprova l a s require dunde r th e regulations , an da s aforme r

Pag e 2 o f 308/17/201 1 100 4 FAX 202493514 2 FA A ^ DM S g]004/02 3 All!: , 16 - 201 1 5:[i9P M REGULATOR? ? AFFAlJl S fJO . 24 0 P . 4/2 3 

### employe e i s no t

forbidde n fro mtestifyin g t o matter s o n whic h h e worked , a s argue db y th e FAA . Respectfull y submitte dthi s 16 ^ da y o f August , 2011 . CyntEiTChandJer-Snel] , Senio r Coainse l Federa l Expres s Corporatio n Corporat e Ai r 362 0 Hack s Cros s Roa d Buildin g B , 3" * Floo r Memphis , T N 3812 5 901-434-836 1 901-434-828 3 fa x f^yrrthiaciVa^filcr-5neIi(Q)fedex.co m CERTIFCAT E O FSERVIC E I hereb y certif

y tha t th e foregoin g ha s bee n serve dvi aFedE x Priorit y Overnigh t o n thi s 16° * da y o f

Atigust , 2011 , t o th e following : Th e Honorabl e Richar dC . Goodwi n Offic e o f Hearings , M-2 0 120 0 Ne w Jerse y Avenue , S E Eas t Buildin g Groun dFloor , R mE12-32 0 Washington , D C 2059 0 202-366-213 9 202-366-753 6 fa x Federa l Aviatio n Admirustratio n 80 0 Independenc e Avenu e S W Washington , D C 2059 1 Atin . Hearin g Docke t

Cler k AGC-43 0 

### Wilbu r Wrigh t Building . Suit e 2W100 0 202-493-514 2 fa x Kyl e Lomazow , FA A Attorne y FA A Offic e o f

Regiona l Counse l 160 1 Lin dAve . S W Renton , W A 9805 7 425-227-184 7 425-227-100 7 fa x

-Snel l Pag e 3 o f 308/17/201 1 10:0 4 FAX 202493514 2 FA A - OM S (2|005/02 3 AUG . IS . 201 1 5:09P M ^hGULATOR YAFFAIR S NO . 2^1 8 PiP . 5/23 3 

### Cynthi a Chandler-Snel l From : sherr i .pappas@dot.go v Sent : Monday . Augus t 15 , 201 1 1:0 2 P M To ; Cynthi a Chandler-Snel l Subject : RE : Revise d propose d question s fo rBo b Richar d Cynthia , A s yo u ar e awar e Bo b ma ytestif yunde roat h unde rpenalt yo f perjur yi f th e testimon yi s withi n th e confine s o f 4 9 CFR Par t 9 an d I S US C 20 7 an d 5 CFR Par t 2641 . T o recap I n an y lega l proceedin g i n whic h th e Unite d State s {includin g an yfedera l agenc yo roffice ro f th e Unite d States ) i s a party : A n employe e tindudin g a forme remployee ) ma yno t testif ya s a n exper t o ropinio n v^^itness , wit h regar d t o an y matte rarisin g ou t o f th e employee' s officia l dutie s o rth e function s o f th e Department , fo ran ypart yothe rtha n th e Unite d State s i n an y lega l proceedin g i n whic h th e Unite d State s I s a parry . A n employe e wh o receive s a deman d t o testif y o n behal f o f a part yothe rtha n th e Unite d State s ma ytestif ya s t o fact s withi n th e employee' s persona l knowledge , provide d tha t th e testimon y b e subjec t t o th e prio rapprova l o f agenc ycounse l an d t o the " Federa l Rule s o f Civi l Procedur e an d an y applicabl e claim s o f privilege . A n employe e ma yno t purpor t t o spea k fo rDO T o rdisclos e an y confidential , sensitiv e informatio n o ranythin g abou t th e deliberativ e proces s o f DOT . Th e pos t employmen t restriction s ar e i n 1 8 US C 20 7 an d 5 CFR par t 2641 . Th e exceptio n fo rtestimon yI s I n I B US C 207(j){6) . Unde rthi s exceptio n a n employe e i s no t prevente d fro m E'^in g testimon yunde roat h o rfro m makin g statement s require d t o b e mad e unde rpenalt y o f perjury . However , thi s exceptio n doe s no t appl y t o th e forme remploye e servin g a s a exper t witnes s wit h respec t t o a particula rmane rfo ran yperso n (excep t th e US ) i n tha t matter . 5 CF R 2641.301(f ) implement s thi s provisio n fo rgivin g testimon yunde roat h a s lon g a s yo u ar e no t servin g a s a n exper t witness . A s applie d t o you rpropose d se t o f questions , i t look s lik e th e question s ar e intende d t o elici t testimon ybase d o n fact s withi n Bo b Richard' s persona l knowledge . Th e question s wil l no t as k fo rhi s opinio n a s a n expert . Th e question s wil l as fo rinformatio n tha t i s withi n Bob' s persona l knowledg e o ri s publi c information . Th e question s wil l no t elici t testimon y tha t wil l disclos e an y confidentia l informatio n o ranythin g abou t th e deliberativ e proces s o f PHMS A o rDOT . I hav e n o objection s t o th e propose d se t o f questions . Sherr i Pappa s Deput y Chia f Counse l Offic e o f Chie f Counse l Pipelin e an d Hazardou s Material s Safet yAdministratio n U.S . Departmen t o f Transportatio n 120 0 Ne w Jerse y Avenu e S E E26-33 4 . Washington . D C 2059 0 202-36S-436 3 sherri . pappastajdo^ , go v

S/15/?,01 108/17/201 1 10:0 4 FAX 202493514 2 FA A " OM S 0006/02 3 AU(^ . 16.201 1 5:D9P(v ] SEGULATOIi Y AFF.Mii S l\!0 . 24 3 ? . 6/2 :



### UNITED STATE S O FAMERIC A DEPARTMEN T O

FTRANSFORATIO N OFFIC E O FHEARING S WASHINGTON , D C In th e Matte r

o f "EA A DOCKE T N O C

P 10NM000 6 FEDERAL EXPRES S CORPORATIO N . FAA CAS E N O 2009NM70005 6 I n th e Matter

o f FAA DOCKE T N O CP10NM000 7 EMPIR E AIRLINE S IN C FAA CAS E N O 2009NM70006 5 FEDEX AN D EMPIRE'S RESPONS E T O FAA\ S MOTIO N IN LIMIN E

AN D RBOUES T FO REXPEDITE D RULIN G TH E HONORABLE RICHARD C . GOODWIN COM E NO W th e Respondents , Fe<l«ra J Expres s Corporatio n (hereinafter "FedEx' ^ andEmpir e Airlines , Inc . (hereinafter "Empire") , an di n respons e t o th e FAA' S 

### Motio n i n Limin e an dReques t for Expedite dRulin g submit s th e following : 1 . I t i s admitte dtha

t FedEx , Empire , an dth e FAA exchange ddiscover>

- o n th e agreed-upo n dat e o f

Augus t 8 , 2011 , wherei n FedE x andEmpire name dBo b Richarda s apotentia l witness . 2 . It i s admitte dthat

Mr . Richardi s th e forme r Deput> ' Administrato r

fo r Hazardou s Materia l Safet> ^ for th e Pipelin e andHazardou s Material s Saiety Administratio n (PHMSA) . FedEx an dEmpir e agre e that ther e ar e requirement s governin g the matter s an dextent t o whic h Mr . Richar dma y testify , uiiic h were addresse di n th e discover y response . FedE x an dEmpire di dno t nam e Mr . Richarda s a n exper t o r opinio n ^^•itnes

5 an dhav e n o intention s o f

usin g Mr . Rjchar

di n any manner

othe r than a s allowe db

y 4 0 C.F.R. , Subtitl e A , Par

t 9 . Pag e 1 o f 308/17/201 1 10:0 4 FAX 202493514 2 FA A - DM S 2|007/02 3 AUG . 16.201 1 5:09P M fiEGULATORY AFF.Mii S NO . 24 5 ' P . l/l l



### 3 . FedE x an dEmpir e reapectfiill y disagre e wit h th e interpretatio n o f th e F.A A i n citin g th e Memorandu mattache da s a n exhibi t t o it s Motion . Whil e th e Memorandum , notabl y an interpretatio n o f th e rule s b> ' aDO T attomc>- , clearl y addresse s tha t

aforme r

employe e i s no t

prohibite dfro mtestif>'in g abou t matter s tha t

h e di dno t

participat e i n o r

wor k o n whil e aDO T employee , th e Memorandu mdoe s no t impl y b y omissio n tha t al l testimon y abou t matter s aforme r

employe e di ^ participat e i n o r wor k o n is , conversely , prohibited . I n fact , suc h testimon y i s expressl y allowed , a s shov-T i i n th e lette r

t o Mr . Richar dfromth e Deput y Chie f Counsc ] fo r PHMSA , Sherr i Pappas , whic h th e FA A include di n it s Supplemen t t o Motio n i n Limin e an dReques t fo r Expedite dHearin g file dAugus t 11 , 2011 . 4 . Mr . Richar dreceive dpemtissio n t o testif> ' vi aemai l o n Augus t 15 , 2011 , fromDeput y Chie f

Counse l Pappas , a s require dunde r 4 9 CF.R , 9.7(b) , pe r th e attache ddocument . 5 . Furthermore , FedE x an dEmpir e hav e cooperate dv,it h th e Agenc y (PHMSA ) b y providin g ahs t o f anticipate dquestion s t o ensur e tha t th e subjec t matte r an dinformatio n solicite ddoe s no t i n an y wa y expos e Mr . Richar dt o scrutin y unde r hi s post-cnaploymc mduties , cithe r tmde r contrac t o r b y legulation . WHEREFORE , PREMISE S CONSIDERED , FedE x en dEmpir e respectfull y submi t tha t th e FAA' s Motio n i n Limin e shoul db e denied , a s th e Agenc y Attorne y ha s provide dapprova l a s require dunde r th e regulations , an da s aforme r employe e i s no t forbidde n fromtestiiyin e t o matter s o n whic h h e worked , a s argue db y th e FAA . Pag e 2 o f 308/17/201 1 10:0 5 FAX 202493514 2 FA A ^ DM S 121008/02 3 AUG . !^ . 20! l 5:09F M REGULATOf^ YAFFAi.^ S NO . 24 6 ? . 8/2 3 

### Respectfull y submitte dth i s 16 * da y o f August , 2011 . Cynthi aChandler-Snel l Senio r Counse l Federa l Expres s Corporatio n Empir e Airline s 362 0 Hacb ; Cros s Roa d Buildin g B , 3" * Floo r Memphis , T N 3812 5 901-434-836 1 90M34-825 3 fax cvnth i 3 „ chandler-snellt^fedex . co m CERTIFCAT E O FSERVIC E I hereb y certif

y tha t th e foregoin g ha s bee n aer.'e dvi aFedE x Priorit y Overnigh t o n thi s 16 * da y o f

August , 2011 . t o th e following : Th e Honorabl e Richar dC . Good\*i n Offic e o f Hearings , M-2 0 120 0 Ne w Jerse y Avenue , S E Eas t Buildiji g Groun dFloor , R mE12-32 0 Washington , D C 2059 0 202-366-213 9 202-366-753 6 fa x Federa l Aviatio n Administratio n 80 0 Independenc e Avenu e S W Washington , D C 2059 1 Attx . Hearin g Docke t

Cler k AGC-43 0 Wilbu r Wrigh t Building , Suit e 2W100 0 202-493-514 2 fa x Kyl e Lomazow , FA A Attorne y F A A Offic e o f

Regiona l Counse l 160 1 Lin dAve . S W Renton , W A 9805 7 425-227-184 7 425-227-1 1

Pac e 3 o f 308/17/201 1 100 5 FAX 202493514 2 FA A - DM S 0009/02 3 AUG . i6 . 201 1 5:09PiV l RtGULATOfi Y AFFAi.^ S MO. 24 S Pagp . 9/2 3 

### Cynthi a Chandler-Snel l From : 3herri-pappas@dot.go v Sent : Monday , Augus t 15 , 201 1 1:0 2 P M To : Cynthi a Chandler-Snel l Subject : RE : Revise d propose d question s fo rBo b Richar d Cynthia . _^

^ ..,,„,_ _' A s yo u ar e awar e Bo b maytestif yunde roat h unde rpenalt y ofpen'uryifth e testimon yi s withi n th e confine s o f 4 9 CF R Par t 9 an d 1 3 USC 20 7 an d S CFR Par t 2641 . T o recap I n an y lega l proceedin g i n whic h th e Unite d State s (includin g an yfedera l agenc yo roffice ro f th e Unite d States ) i s a party : A n employe e {includin g a forme remployee ) ma yno t testif ya s a n exper t o ropinio n witness , wit h regar d t o an y matte rarisin g ou t o f th e employee' s officia l dutie s o rth e function s o f th e Department , fo ran ypart yothe rtha n th e Unite d State s i n an y lega l proceedin g i n whic h th e Unite d State s i s a party . A n employe e wh o receive s a deman d t o testif y o n behal f o f a part y othe rtha n th e Unite d State s ma ytestif ya s t o fact s wixhi n th e employee' s persona l knowledge , provide d tha t th e testimon y b e subjec t t o th e prio rapprova l o f agenc ycounse l an d t o th e Federa l Rule s o f Civi l Procedur e an d an yapplicabl e claim s o f privilege . A n employe e ma yno t purpor t t o spea k fo rDO T o rdisclos e an y confidential , sensitiv e informatio n o ranythin g abou t th e deliberativ e proces s o f DOT . Th e pos t employmen t restriction s ar e i n I S US C 20 7 an d 5 CF R par t 2641 . Th e exceptio n fo rtestimon yi s i n 1 8 US C 207(j){6) . Unde rthi s exceptio n a n employe e i s no t prevente d fro m givin g testimon yunde roat h o rfro m makin g statement s require d t o b e mad e unde rpenalt yo f perjury . However , thi s exceptio n doe s no t appl yt o th e forme remploye e servin g a s a exper t witnes s wit h respec t t o a particula rmatte rfo ran yperso n (excep t th e US ) i n tha t matter . 5 CF R 2641.301(r' ) Implement s thi s provisio n fo rgivin g testimon yunde roat h as lon g a s yo u ar e no t servin g as a n exper t witness . A s applie d t o you rpropose d se t o f questions , i t look s lik e th e question s ar e intende d t o elici t testimon ybase d o n fact s withi n Bo b Richard' s persona l knowledge . Th e question s wil l no t as k fo rhi s opinio n a s a n expert . Th e question s wil l a

s fo rinformatio n tha t i s withi n Bob' s persona l knowledg e o rI s publi c Information . Th e question s wfl l no t elici t testimon y tha t wil l disclos e an y confidentia l informatio n o ranythin g abou t th e deliberativ e proces s o f PHMS A o rDOT . I hav e n o objection s t o th e propose d se t o f questions . Sher n Pappa s Deput y Chie f Counse l Offic e o f Chie f Counse l Pipelin e an d Hazardou s Material s Safet y Administratio n U.S . Departmen t o f Transportatio n 120 0 Ne w Jerse y Avenu e S E E26'33 4 Washington , D C 2059 0 202-366-136 3 sherrt.pappasfa^ot.qQ v



### 8/15/201 108/17/201 1 10.0 5 FAX 202493514 2 FA A - OMS i2]010/02 3 AUU . 16.Kl] l 5:10P M i^tGUL;lTOR Y AFFAIR S NO . 24 3 P . iO/2 3



### UNITED STATB S 

### O F.AMERIC A DEPARTMEN T O FTRANSPORATro N OFFIC E O FHEARING S WASHINGTON , D C In th e Matter

of . FA A DOCKE T N O CP I ONMO O 1 1 FEDERAL EXPRES S CORPORATIO N FAA CAS E N O 200SNM70012 7 I n th e Matte r

of FA A DOCKETN O CPIONMOOI O CORPORATE AI RFAA CAS E N O 200SNM70012 6 FEDE X AND CQRPORATF . AXR' R 

### MOTIO N T O ALLO W TESTIMON Y O FWITNES S DISCLOSE D AFTER

DISCOVERY DEADLINE TH E HONORABLE RICHARD C . GOODWIN COM E NO W th e Respondents , Federal Expres s Corporatio n (hereinafter "FedEx" ) an dCorporat e Air , an dmov e thi s Honorabl e Cour t t o allo w th e Respondent s t o cal l awitnes s v/ho wa s disclose dt o th e FA A afte r th e disco^'er

y deadline . In suppor

t o f thi s motion

^ th e Respondent s submi t tha t th e FA A vd

U no t b e prejudice db y this late disclosure , a s discover

y i n thes e matter s wa s extende db y verbal agreemen t o f th e partie s unti l Monday, . Augus t

8 , 2011 , andthi s disclosure occur s onl y aweek followin g tha

t disclosure . Furthermore , th e Respondent s submi t tha t th e witness , Dr . Basha

r DabbaS : wil l giv e limite dtestimon y o n th e effec t o f any change s i n transportin g UN337 3 shipment s o n th e healthcar e industry an do n M s patients . Thi s testimon y i s i n th e publi c interes t an d wil l no t i n any way prejudic e th e FAA . I n fact , th e Respondent s agre e t o provid e Dr . Dabba s fo r depositio n b y phon e i f

require dprio r

t o th e trial o f

this matter , althoug h w e woul dpoin t

ou t that non e o f th e partie s t o thes e matter s hav e depose dan y witaesse s

Page l o f 308/17/201 1 10:0 5 FAX 202493514 2 FA A ^W S ' @011/02 3 Aijij . Ib.-^Ul l !);iOPV i R:G'dl.ATO^ Y AhfAlR S tJO . 24 8 ? . ii/2 3



### liste di n tli e discovery . A cop y o f Dr . Dabbas * Curriculu mVitae i s attache dan dwa s provide dt o th e FA A o

n th e 15*da y o f

August , 2011 . I n addition , th e Respondent s submi t that they were no t

aware o f th e availabilit> ' or existenc e o f

thi s wimes s unti l Friday , Augus t 12 , 201 L A s informatio n o n th e schedule d trial o f this cas e spreadthroug h th e companie s an dth e transportatio n industr>' , anda s man y sector s wil l b e effecte db y th e outcome o f Thi s matter other than carriers , witnesse s hav e com e forwar

drequestin g t

o appea r before th e cour

t t o testif> ' a s t o th e echoin g effect s o f th e propose dinterpretatio n o f thi s rul e a s applie dt o FedEx an dCorporate Air . WHEREFORE , wit

h goo dcaus e demonstrated , FedEx an dCorporat e Air respectfull y reques t

that th e lat e disclose d-witnes s b e allowe dt o testif y a t th e tria l o f

thi s matter . Respectfully submitte dthi s 16 * da y o f August , 2011 . ,ynthi aChandler-Snel l Senio r Counse l Federa l Expres s Corporario n Corporate Ai r 362 0 Hack s Cros s Roa d Buildin g B , 3' ^ Floo r Memphis , TN 3812 5 901-434-836 1 901-434-828 3 fa

x cvnfhia.chandler-snell^.fedex.co m

Pag e 2 o f 308/17/201 1 100 5 FAX 202493514 2 FA A - DM S @|0l2/02 3 

### rtu^3- !ti . ZUl

i : : 1',1^' W KhG'JlAlOS

Y AfrAlR S m . 24 S P . i2./2 3

CERTIFCAT E O FSERVIC E I hereb y certif

y that th e foregoin g ha s bee n serve dvi aFedE x Priority Overnight o n thi s 16 ^ da

y o f August , 2011 , t o th e following : The Honorabl e Richar dC . Goodwi n Offic e o f Hearings , M-2 0 1200 Ne w Jerse y Avenue , S E Eas t Buildin g Groun dFloor , RmEI2-32 0 Washington , D C 2059 0 202-366-213 9 202-366-753 6 fa

x Federal A\ititio n Administratio n 800 Independenc e Avenu e S W Washington , D C 2059 1 Attn . Hearin g Docke t

Cler k AGC-43 0 Wilbur Wright Building , Suite 2W100 0 202^93-514 2 fa

x JB^yl e Lomazow , FA A Attorne y FA A Offic e of

Regional Counse l 160 1 Lin dAve . S W Renton , WA 9805 7 425-227-1S4 7 425-227-100 7 f

a Cynthi aChandler

Pag e 3 of 309/17/201 1 10:0 5 FA X 202493514 2 FA A liriv i .^cbULAlUK V ArrAi'K i - OM S 

### m24 3 0013/02 3 

### ? . 13/2 3

Qash^ r Dabbas , MJD . Curriculu mVita e Professiona l Experienc e Apri l 2006-Presen t Aug . 2005-Pre5eD : Aug . 2005'Presen t March . 2004-Jul y 200 5 Jan . 1999-July 200 5 Jan 1998-July 200 5 Nov . 1992-Jul y 200 5 Nov . 1992-Dec.200 2 July 1991-Nov , 199 2 Jul y 1991-Nov , 199 2 Academi c Appointment ? Nov . 1992-Dec . 200 5 Nov . 1991-Nov . 199 2 Jul y 19gS'Jun e 199 0 Jul y 1989-Jun e 199 0 Jul y l9S6'Jun«19a 9 Postgraduat e Trainin g Jul y 199(>-Juiiel99 l Jul y 1989-Juii e 199 0 Jul y lP88-Jua e 199 0 Jut y 1985-Juii e 198 9 Jul y 1986-Jun e 19S 7 Medica l Educatio n Sep . 1977-Aug . 198 3 Undergraduat e Trainin g Sep . 1982-Aus . 198 3 Jul y 19S2-Sept . 198 2 Jul y 1981-Oct . 19S 1 America D Boar dCertification s Jun e 199 2 Aug . 199 0 Medica l an dLaborator

y Director , Oeaopti x Clinical Laboratory . Senio r Htmatopathologist , Geaopti x Medical L^boratoi^' . President an dChie f

Medica l 0£ficer , Cartesia

n Medical Group , Inc . President , Uta

h Paiholog y Servicfis , Inc . Salt Lak e City , Utah . Medica l Director , Electro n Microscop y an dIH C Laboratories , LD S Hospital . Designate dPathologist , Bou t Mano^v Transplant

Prosram , LD S HospitaJ

Consultant

i n Cardiac Pathology , Universit y o f Uta h Medical Center . V

A Medical CeLi«r , andPtimar y Childien' t Medical Center , Sal t

Lake City , Utah . Medica l Director , Flo w Cytometr y Laboratory , LD S Hospital . Associate Pafliologist , Scot t & "^/hit ? Hospital &

: Clinic , Temple , Texas . Ciiie£Sectio n o f

Inununopathobgy , Scot

t & White Hospital & Clinic . Cliaical Assistan t

Professo r o f Pathology , University o f

Utah . Assist^ : Professo r

o f Pathology , Texa s A&MUnivenit y Colles e o f Medicine . Associate Clinical lastructor , Wrigh t Stat e University . Gues t Lecturer , Kettcria g Collei e o f Medical Arts , Dayton , Ohio . Gues t Lecturer , Schoo l o f

Medical Technology , Dayton , Ohio . Fello w i n Hemftopathobgy , Universit y o f Uta h Medical Center . Fello w i n Surgical Pathology , Wrigh t Stat e Unjvcrsity/Kecterin g Medical Center . Chie f Residen t i n Pathology , Wright

Stat e University/Ketierin g Medics ] Center . Residen t i n Antttomi c andClinical Pathology , Wrigfc c Stat e Uoiversiiy . Schoo l o f Medical Technology , Kctierin g Colleg e o f Medical Ans . Ohio . Damascu s University Schoo l o f MediciDC , Damascus , Syria , M.D . Degri^c . Rotatin g Interaship , Damascu s Universit y Hospitals , Damascus , Syria . Rotatin g Exismship , Department s o f Interna l Medicin e andSurgery , University o f Newcartle/Hartlepoo l Genera l Hospital , England . Rotaiio g Extenwbip , Departmen t o f Interna l Medicine , Wiigh t

Slate University . Subspecialt

y Board s i n Hematopaihology , 5Q92-078 . Diplomatc . Th e America aBoard s o f Anatomi c an dClinical Pathology , 90-126 .08/17/20 1 1 1 0 0 5



### AUG , 16 . 

### 201 1 FA

X 202493514 2 FA A 5;)DF. M REGULATOR YAFFAiR'; : - DM S 

### NO . 24 3 0 14/02 3

Medica l Licensur e Nov . 2005-Presen t Ma y 1990-Present Ma y 1990-PTesen

t Nov . L^Pl-Prtsenr Jun e 2006-Present Jua c 1990-Prcscnt Honors/Award s Jun e 199 0 Stat e o f California , lici!Dse#C5213 4 Stat e o f Utah , license d90-1S2304-1205 , 90-182304-991 5 Stat e o f Ohlahoma , licens e #1722 6 Slat e o f Texai . licens e A^JO^6

6 Stat e o f Nft w Yor k Certificate o f

Qualificatio n i n Cellula

r Immunology , Hematology ^ Genera

l Histopafhology , an dCytopathology , #CQP31528 . Controlle dSubstanc e Licens e #BD24P295 2 Hele n Popowa

y Researc h Award , Ketterin g Medical Center . Researc h Eitperieac c Kov.2002-.Tuly 200 5 Nov . 2001-Jul y 200 3 Jul y 3001-Jul y 200 5 Nov . 200 1 Jul y 200 5 Apri l 2001-Jul y 200 5 Apri l 2001-Iul y 200 5 Apri l 2001-JuIy 200 5 Marc h 2001-Jul y 200 5 Jan . 2001-July 200 5 Apri l 2001-Aug . 200 1 Jul y 2000'JuI y 200 5 Jul y 1989-Jul y 199 0 Apri l 198 8 Jun e 1P8 6 Predictiv e andprognosti c factor s fo r patient s wit

h multipl e myelom aundergoin g hig h dos e chemotherap y an dautologou s pte mc«i l rescue . Molecula r marker s an

dthei r coirelatio n ^vit

h respons e t

o theaap y an dsurvival i

n patient s wit

h malignant

gliomas . Anonyniiie dcollecDon o f participan t

tissue an dphenotj-pi c dat afo j inclusio n i

n arepositor

y an dus e i n genetic s researc h studies . Cardiac valvulA

r change s followin g L-VA D an dR-VAD placement . Incidenc e an dsignificanc e o f DK A repai r protein s i n th e tumor

specimen s o

f patient s with malignan t

astrocytoma s treate dwit

h irradiatio n an dECNU . PS 3 MidniisinatchTepairE^eMLH-i , i n Cisplatinum-reeistan t human ovarian cancer colls . Mismatc h repai r

gene MLH- 1 i n human ovarian cancer cell s A2780 . Ligaa dexpressio n i n restin g an dhoimonoll y induce dovarian cells . Identificatio n o f

P5 3 respons e element

i n ovarian cancer

cells . Ris k factor s i n steroid-resistan t caxdia c allograf t rejection . N'oa-Hodgkin' s Lymphoma , diagnosti c difKculties , pattern s o f practic e i n th e community , juidinter

- an dintra

- observer diagnosi s reproducibility . Quantitativ e Assessment

o f Non-Atypical Flori dEpithelial Hypeipla^i ao f th e Breas t andTh e Ris k o f Carcinoma . Adriamycin-induce dCardiac Toxicit y an dSerumCreatin e Kinas e Level s Measureineji t

o f Glycosylate dHemoglobin s b y Colum n Affinit y an dIoni c Exchang e Chronmiography

Publication s Fals e Posiuv e PE T Scai

mInvolvin g th e Splee n inTv o Paticni awit h Aggrassiv e Nou-Hodsjd n Lymphoma . ClmNudMed . 2006;31:391- 3 Utilit y o f Histologi c Paraioefer s i n Screenin g fo r Antibody-mediate dRejectio n o f th e Cardia c Allograft : A Stud y o f 317 0 Biopsies . J Hear

t Lun g Tiaosplant . 2005;24:2015-21 . Histon e Deacerylas e Inhibitor s Induc e G2-checkpoin r Arres t an dApoptosi s i n CispUtifium-Rtsistaii t Ovaria n Cance r Cell s Associate dwit

h Overexprtssio n o f

th e BCL-2-relatc dfTotein Bad . Mo l Cancer Ther . 2005 ; 4 , 603-11 .OS/17/201 1 1 0 0 6 FAX 202433514 2 FA A- DM S 13015/02 3 hu o io . /U N5:IL)r M KMiULAlOR Y AFFAi.^ S NO . 24 6 P , 15/2 3

Earl y Failur e o f

aTricuspi dValv e Replacemen t wid i aMitrilVdIv e Horrograf t i n aHear t Transplant Recipien t J Heart Lun g Transplant . 20W ; 23:1460-2 . Cel l Type-Dependent

Regulatio n o f

hMLH l Promoter

Activit y i s Influence db y th e Presenc e o f Multipl e Redundan t

Elements . Mo l Cancer

Res . 2003 ; 1:610-8 . Ce U Cycl e Blockad e andDifferentiatio n o f Ovaria n Cancer C^ll s b y th e Histon e Deacetylas e Inhibitor Trichoslati n A are Associate dwit h Charge s i n p21,Rl> , an dI dProteins . Mo l Cancer Thcr . 2002 ; lillSl

90 . EJCptessio n i n A278 0 Ovaria

n Cancer Cells . JBiolChe m2001 ; 20:276:27363-70 . Idiopathi c Hypcreosinophili c Syndrome . ASC P Chec k Sample . I994;H94-I . Chroni c Myelomonocyti c Leukemia . ASC P Check Sample . 1991 ; H9I-9

- Acut e Biphemotypi c LeukeiLia . ASC P Check Sample , 1991 ; H91-7 . polycythemi aVeraEvolvin g int o Acm e Myeloi dLeukemia . ASC P Chec k Sample . 1991 ; H91-6 . ThiomboacThrombocyiopeni c Purpura . ASCP Check Path . I990;AQ5036 . Clinicall y Significant

Virusea . A

n Update . AM T Events . I989;4.33-«9 . Th e Acute Abdometi- . A Doctoral Thesis . Damascu s UnivenlTy Press , 1983 . Uiiluenc e o f

Etiolog y o f

Heart Failure o n th aPrognosti c Significanc e o f HLA-Dr 3 aitft

r Hear t Transplantarioa : Evidenc e forEohaiice dHumora l Immunity ' i

n Idiopatiil c Dilate dCardiomyopathy . (Submitte dfo

r pubUcatio n i

n th e America

n Jouma ] o f

Tranaplantaaon) . Ab^ract s Cardiovascula

r Death s i n Heart Transplan t

Recipients ; Doe $ th e •Rejectio n Pattern MaUera ? Th e ifltcmadonal Societ

y o f Hear t an dLun g Transplantatio n 25 * Annual Meetin g an dScientifi c Sessions . Philadelphia . April , 2005 . D N A Repair

Protein s a s Predictiv e Factor s fo r Lon g ter mSurvival i n Patiait s wjt

b Glioblanom a Multiforme Receivin g Post-operativ e Irradiatio n an dNitrosoureas , aPossibl e Rol e fo r DN A Mismatc h Repair , P53 , andERCC! : A Radiatio n Therap y Oncolog y Grou p Study . ASC O Meeting , Ne w Orleans , June , 2004 , Lon g Ter mSurvivor s wit

h Glioblastom aMultiforme (GBM ) Treate d-<vii h Irradiatio n an d'Nitrosourea s Hav e Highe r

Initial Expressio n o f

Ki-67 . ASC O Annual Meeting , Ne w Orleans . June , 2004 . Expressio n o f

DN A Repai r

Molecule s 1

5 no t aSignificant

Prognosti c Puctc r

fo r Lon g Ter mSurvivori wit

h Glioblastom aMultiforme (GBM ) Receivm g IriBdiatio n an dNitrosoureas . ASC O Annual Meeting , Ne w Orleans , June , 2004 . L-ong-te mSurvivor ? witi i Glioblastom aMultiforme Treate dwit h Irradiatio n an dHitrosoure aHav e Higher Initial Expressio n o f

Ki-67 . ASC O Annus I Meeting , Ne w Orleans , June , 200J . Effect s o f Trichostati n A o n Cel l Growt h an dth e Expreasio n o f

Cel l Cycl e andApoptosis-relate dFactor s I n Plstinum-resistan t

Ovarian Carcinom aC^l ! Lines . America n Associatio n o f

Cance r Research , Toronto , Canada , April , 2003 .08/17/201 , 100 G FAX 202493514 2 FA A ' DW S 30,6/02 3 mu . lu.ZLM ! ^M'Jf

M HtljULAIOR

V AFrAlRc ' MO . 24 o F . lb/2 3

Pattia l Aori c Valv e Fusio n Relate dt o LVA D Support . Hear

t Failur e an dCirculator

y Suppor t Summit Conference , July , 2002 . Ris k Facto r fo r Persisie mo i Recurren t

Steroid-Resistan t

Cardia c Allograf

t Rejection ; I s Pte-uansplan l Diagnosi s o f

Idiopatfai c Dilate dCardiomyopathy aRisl c Facto r Associate dWit

h Poo r Outcome ? America

n Hea n Societ

y Annual Meeting , Ma y 20&1 . ?o5te r FresentatioD S

. De.ve!orimeQ

E o f a n AssaY.fi:i

r 06tecilQt!-pf.M£L^i^l5I.-aiLdK.M.uiatlQn aPain s Invade r PJu^^'^.^DKjf

l , Periphera l Bloo dan dBon e Marro w Aspirates . OptiniB l Preparatio n o f

He5atttoU>gi

c Smears . Presente da t

th e Pa n Pacifi c Lymphom aConference , Maui , Hawaii , Jun e 2007 . ImmuDophenctyp e Associate dwit h Down' s Syndrom

e LeuJcemiaan dTransien t Myeloproliferativ e Disorder . Presente ds t

th e Clinical Application s o f Plo w Cyiometr

y Aicmua l Meeting , Orlando , Honda , Nov . 2001 . Ris k Facto r fo r Persisten t

o r Recorrcnt

Steroid-Resistan t

Cardia c Allograf

t Rejection. " I s Pre-transplap * Diagnosi s o f

Idiopathi c DilaTe

dCardiomyopath

y aRis k Facto r Associats dWit

h Poo r Outcome" ) Presente d a t th e America

n Hea n Associatio n meetin g i n Anoheim , Ca , November , 200 1 Th aUtility o f

CD79 aa s aMarke r

o f B-cel l Lmeflg e i n Flo w Cytometri c Evaluatio n o f Acnte Leukemifl . Pixsente da

t th e CVmica

l Application s o f

Flo w Cjlometr y Annual Meeting , Austin , Texas ^ Nov . 2000 . Frofesslona l Societ

y Fellowship s an dMerabersWp s Interaational Academ

y o f Patholo£ y Unite dStale s an dCanadian Academ y o f Pa'^olog y Colleg e o f

American Pathologist s Aiflerica n Societ y o f H«rrratolog y America n Societ y fo r Clinical Parholog y Intfimationa ] Societ

y fo r Analyiical Cytolog y Clinical Cytometr

y Societ y Societ y fo r Hematopaiholog y hitematioTia

dSociet y fo r Laborator

y Hematolog y Ketterin g Alumn i Asapciatio n Refejence s Reference s wil l b e provide dupo n reques t 3/201 108/17/201 1 10.0 6 FA X 202493514 2 FA A - DM S @017/02 3 

## AUG . i6 . 201 1 5:iO? M hEGULATOR V AFFAiS S NO , 24 3 P . \l/2 2

U^^ITE D STATIE S O F

### AMERIC A DEPARTMENT O FTRANSPORATIO N OFFIC E O FHEARING S WASHINGTON , D C I n th e Matte r

o f FAA DOCKLE T N O C P 10NM000 6 FEDERAL EXPRES S CORPORATIO N FA A CAS E 

### N O 2009NM70005 6 In th e Matte r

o f FA A DOCKET N O CP10NM000 7 EMPIR E AIRLINE S IN C FA A CAS E N O 2009NM70006 5 FEDE X AND EMPIRF.' S MOTIO N T O AT.LO

W TESTIMON Y O FWITNES S DtSCl-OSE D AFTE R DISCOVERY DEADLi;>r

H TH E HONORABLE RICHARD C GOODWI N COM E NO W th e Respondents , Federal Expres s Corporatio n (hereinafter "FedEx" ) aii dEmpire AirUnes , Inc . (hereinafter "Empire") ? andmov e this Honorabl e Cour t t o allo w th e Respondent s to cal l awitnes s wh o wa s disclose dt o th e FA A afte r th e disco^ver y deadline . I n suppor

t of this motion , th e Respondent s submi t that th e FAA wil l no t b e prejudice db y thi s lat e disclosure , a s discover y i n thes e matter s ^va

s extende db y verbal agreemen t

o f th e partie s unti l Monday , Augus t B , 2011 , an dthis disclosur e occur s onl y aweek

followin g that

disclosure . Furthermore , th e Respondent s submi t that th e witness . Dr . Basha

r Dabbas , wil l giv e limite dtestimon y o n th e effect of an y change s i n transportin g UN337 3 shipment s o n th e healthcar e industr

y ando n hi s patients . Thi s testimon y i s i n th e publi c interes t an d •wil l no t i n any wa

y prejudic e th e FAA . I n fac t th e Respondent s agre e t o provid e Dr . Dabba s fo r depositio n b y phon e if

require dprior

t o th e tria l o f

this matter , althoug h w e woul dpoin t

ou t that non e o f th e partie s t o thes e matter s hav e depose dany witnesse s

Pag e 1 o f 308/17/201 1 10.0 6 FA X 202a935ia 2 FA A- DM S 1^018/02 3 .'\iJti . i6 . 201 1 5:riF M SEGl'LATOR V AFFAU S MO . 24 8 ? . i3/2 3



### liste di n th e discovery . A cop y o f Dr . Dabbas ' Curriculu mVita e i s attache dan dwa s provide dt o th e FA A o n th e IS'* ' da y o f August , 2011 . I n addition , th e Respondent s submi t tha t the y wer e no t

awar e o f

th e a\'ailabilit y o r existenc e o f

thi s wimes s unti l Friday , Augus t 12 , 2011 . A s informatio n o n th e schedule d tria l o f thi s cas e sprea dthroug h th e companie s an dth e transportatio n industry , an da s man y sector s wil l b e effecte db y th e outcom e o f thi s matte r

othe r tha n carriers , witnesse s hav e com e forwar drequestin g t o appea r befor e th e cour t

t o testif y a s t o th e echoin g effect s o f th e propose dinterpretatio n o f thi s rul e a s applie dt o FedE x an dEmpire . WHEREFORE , wit h goo dcaus e demonstrated , FedE x an dEmpir e respectfijll y reques t tha t th e lat e disclose dwitnes s b e allowe dt o testify

- a t th e tria l o f

thi s matter . Respectfull y submitte dthi s 16 ^ da y o f August , 2011 . ?>TitEaChandler-Snel l Senio r Counse l Federa l Expres s Corporatio n Empir e Airline s 362 0 Haclc s Cros s Roa d BuildmgB , 3"^Floo r Memphis , T N 3812 5 901^34-836 1 90M34-S2S3fa x cvnthia . chandler-snellfSifede x .co m

Pag e 2 o f 308/17/201 1 10:0 6 FA X 202493514 2 FA A - Df'^ S @]018/02 3 AUG . I& . 2[)i l 5:nf M iltGUlATO!< V AFFAIK S '^^•2^ 5 f - -'^'^2 3

CFRTTFCAT E 

### O FSERVIC E I hereb y certif

y tha t th e foregoin g ha s bee n serve dvi aFedE x Priorit y Overnigh t o n thi s 16 ^ da y o f

August , 2011 , t o th e following : Th e Honorabl e Richar dC . Goodwi n Offic e o f Hearings , M-2 0 120 0 Ne w Jerse y Avenue , S E Eas t Buildin g Groun dFloor , R mE12-32 0 Washington , D C 2059 0 202-366-213 9 202-366-753 6 fa x Federa l Aviatio n Administratio n 80 0 Independenc e Avenu e S W Washington , D C 2059 1 Attn . Hearin g Docke t

Cler k AGC-43 0 Wilbu r Wrigh t Building , Suit e 2W100 0 202-493-514 2 fa x Kyl e Lomazow , FA A Attorne y FA A Offic e o f

Regiona l Counse l 160 1 Lin dAv e S W Renton , W A 9S05 7 ' 425-227-184 7 425-227-100 7 fa x .ynthi aChandler-Snel l

Pag e 3 o f 308/17/201 1 10:0 6 FA X 202493514 2 FA A 

### AUG . 16 . 2[H 1 5:11P M REGULATOk V AFFAIR S DM S 

### ) . 24 3 121020/02 3 

### P. 23/2 3

Busha r Dabbas , M.D . Curriculu mVita e Professiona l Experienc e Apri l 2006-Prtacn i Aug . 2005-Presen c Aug . 2005-Prcsen t March . 20fW-Ju] y 200 5 Nov . !992-Julv200 5 Jan . 1999-July200 5 Ja n 1998-Jul y 200 5 Nov . 1992-Ju]y200 5 Nov . 1992-Dtc . 200 2 Jul v 1991-Nov . 199 2 Jul y 1991-Nov . 199 2 Academi c Appointment s Nov . 1992-Dec.200 5 Nov . 1991-Nov . 199 2 Jul y 198S-Jmi 6 199 0 Jul y 1989-JuD e 199 0 Jul y 1986-Jun e 198 9 Postgradaat e Trainin g Jul y 1990-Jun e 199 1 Jul y 19B9-Jun c 199 0 Jul y 1988-Tun e 199 0 Jul y 1985-Jun c 198 9 Jul y 1986-Jun c 198 7 Medica l Edacitio n Sep . 1977-Aug . 198 3 Undergraduat e Trainin g Sep . 1982-Aug . 198 3 Jul y 1982-Sept . 198 2 Jul y 1981-Oci . 198 1 Americaj aBoar dCertification s Jun e 199 2 Aug . 199 0 Medica l an dLaborator y Dirccior , Gchopti- X Clinica l Laboratoiy . Senio r Hematopithologist

j Genopti x Medica l Laboratory . Presldoo l an dChie f

Medica l Officer , Cartesia n Medica l Group , Inc . President , Uta h Patholog y Services , Inc . Sal t Lak e Cit>' , Utah . Staf f PathologiiT , LD S Hospital . Medica l Director , Eleciro n Microscop y an dUi C Laboratories , LD S Hospital . Dtsignate dPathologist , BoQ e Mano w Transplan l Program , LD S Hospital . Consultan t

i n Cardia c Patholosy . Universit y o f Uta h Medica l Center , V' A Medica l Center , an dPrimar y Children' s Medica l Center , Sal t Lak e City , Utah . Medica l Director , Flo w Cyromtti j Laboratory , LD S Hospi^

- Associai e Fathologist , Scot t i Wiil c Hospita l &. Clinic , Temple , Texas . Chief , Sectio n o f

Immunopathology . Scor t & 'Whit e Hospita l & Clinic . Clinica l Assistan t

Professo r

o f Pathology , Universit y o f Utah . Assistan t Professo r

o f Paahology , Texa s A& M Univcrsit\ ' Colleg e o f Medicine . Associat e Clinica l Instructor , Wrigh t Stat e Univ-ersir>'

- Gues t Lei^nu'er . Ketterin g Colleg e o f Medica l Arts , Dayton , Ohio . Gues t Lecturer . Schoo l o f

Medica l Technologj' , Da>ton , Ohio . Fello w i n Hematopathology , Universit y o f Uta h Medica l Center . Fello w i n Suisica i Pathology , Wrigh t Stat e Univcnity/Ketterin g Medica l Center , Chie f Residen t i n Palholog>' , Wrigh t

Stat e University/Ketterin g Medica l Center . Residen t i n Anatomi c an dClinica l Pathology , Wrigh t Stat e Un-'vcr^iy . Schoo l o f

Medica l Technology , Kettering . Colleg e o f Medica l Arts , Ohio . Damascu s Universit y Schoo l o f Medicine , Damascus , Syria , M.D . Dcsree . Rotatin g Internship , Damascu s Universit y Hospitals , Damascus . Syria . Rotatin g Extemship . DepartinenT S o f Interna l Medicin e an dSurgery , Universit y o f Newca.irle.'Hartlepoo I Genera l Hospital , England . Rotatin g Extems>iip , Departmen t o f Interna l Medicine , Wrigh t Stal e Universitj- . Subspecialty

- Board s i n Hematopathology , SQ92-07S . Diplomate . Th e America n Board s o f Anaiomi c an dClinica l Pathology , 90-126 .08/17/201 1 10:0 6 FA X 

### AUG . 16 . 20i i 5 : 202493514 2 FA A 1P M REGULATOR Y AFFAU S - DM S 

### )J0 . 24 8 @]02l/02 3 

### '•- . 21/2 :

Medica l Lic«niur e Nov . 2005-Presen t May 1990-Presen l Ma y l990-PTe5<m

t Nov . 1991-Present Jun e 2006-Presen t Jan e 1990-Presfliit Honors/Award s Jun e 199 0 State o f California , licens e #C5213 4 State ofUtah , licens e 1^90-182304-1205 , 90-182304-991 5 Slat e o f Oklahoma , licens e U 1722 6 State o f Texas , licens e #J046 6 Stat e o f Ne w Yor k Certificate o f

Qualificatio n i n Cellula

r Immunology , Hemaiolog>' , General Histcpathology , an dCytopathology , fr CQP315?.8 . Controlle dSubstanc e Liccm e i * BD249295 2 Hele n Popows y Researc h Award , Ketterin g Medical Center . Researc h Experienc e Nov . 2002-JuIy 200 5 Nov . :001-Jul y 200 5 Jul y 2001-Jul y 200 5 Nov . 2001Jul y 200 5 Apri l 200UJul y 200 5 Apri l 2001-Juh'200 5 Apri l 2001-Jul v 200 5 Marc h 2001-Ju b 200 5 Jan . 2001-Jul y 200 5 Apri l 2001-Aug , 200 1 Jul y 2000-Jul y 200 5 Jul y 1989-Jul y 199 0 .-^pri l 19S 5 Jun e 198 6 Predictiv e an dprognosti c factor s fo r patient s w*it

b multipl e myelom aundergoin g hig h dos e chemotherap y andautologou s ste mcel l rescue . Molecula r marker s an dthei r

correlodo n wit

h respons e t o therap y an dsurvjva) i n patient s wit

h malignan t

gliomas . Anonymize dcollectio n o

f participan t

tissu e an dphenotypi t

dai afor inclusio n i

n arepository an duse.i n genetic s researc h studies . Cardiac \'alvular

change s followin g L-VA D andR-VA D placement . Incidenc e an dsignificanc e o f DN A repai r piotein i i n th e tumo r

specimen s o f patient s uit h malignan t

astrocytoma s treate dwit

h irradiatio n an dBCNU . P5 3 an dmismatc h repai r

gen e MLH- 1 i

n Cisplatinum-resistan t

huma n ovarian cancer cells . Mismatc h repai r

gen e MLH- 1 i n huma n ovarian cancer cell s A2780 . Lignn dexpressio n j n restin g an dhormonaUy induce dovarian cells . Identificatio n o f

P5 3 respons e elemen t

i n ovarian cancer

cells . Kisf c factor s i n steroid-resistan t cardia c allograf

t rejection. Non-Hodgkin' s Lymphoma , diagnosti c difficulties , pattern s o f practic e i n th e community , an dintn-

- an dintra r obser\'c r diagnosi s reproducibiJiTy . QuanctTativ

e Assessment

o f Non-Atypical Flori dEpithelia l H>-perpJasiao f th e Breas t an dth e Ris k

o f Carcinoma . Adriamycin-Induce dCardia c Tcxicity an dSeru mCreatin e Kinas e Level s Measuremen t

o f Glycosylate dHemoglobin s b y Colum n Affinit> ' an dIoni c Exchang e Chromatosraph y

Publicarion s Fals e Positiv e PE T Scan s Involvin g th e Splee n i n Tw o Patient s wit

h Aggressiv e Non-Hodgki n Lymphoma . ClinNuclMed . 2006;31:391- 3 Utilit y o f Histologi c Parameter s i n Screenin g for Anabody-mediate dRejectio n o f th e Cardia c Allograft : A Stud y o f 317 0 Biopsies . J Hear

t Lun g Transplant . 2005;24:2015-21 . Histon e Deacetylas e Inhibitor s Induc e G2-checkpoin t Arres t an dApoptosi s i n Cisplaiinum-Resistan t Ovaria n Cancc i Cell s Associate d%vit h Ovcrcxpiessio n o f

ih c BCL-2-relaie dProtei n Bad . Mo l Cancer Ther . 2005 ; 4 , 603-U ,08/17/201 1 10.0 7 FAX 202493514 2 FA A - OM S ^022/02 3 AUG.16.2Cl i 5:]i^ M ,sEGULATOi;; yAFFAIR S HO . 24 8 r . 22/2 5

Earl y Failur e o f

aTricuspi dVaW

e Replacemen t

wit h aMitral Valv e Homograf l i n aHear t Transplant Recipient . J Hear

t Lun g Transplant . 2004;23:1460-2 . Cel l Type-Dependen t

Regulatio n o f

hMLH l Promoter

Activity i s Influence db y th e Presenc e o f Multipl e Redundan t

Elements . Mo l Cancer

Res . 2003 ; 1:610-8 . Cel l Cycl e Blockad e an dDifferentiatio n o f Ovarian Cancer

Cell s b y th e Histon e Deacet>ias e Inhibito r Trichosrati n A are Associate dwit h Change s inp21 , Rb , an dIdProteins . Mo l Cancer Ther . 2002 ; 1:1151

- 90 . Identificatio n o f

ap5 3 Respons e Elemen t

i n th e Promote r

Regio n ofthchMSH 2 Gene , Require dfo r Expressio n i

n A27S 0 Ovarian Cancer

CelJa . JBiolChe m2001 ; 20;276:27363-70 . Idiopathi c Hypereosinophili c Syndrome . ASC P Check Sample . 1994;H94-1 . Chroni c Myelomonocyti c Leukemia . ASC P Chec k Sample . 1991 : H91-9 . Acute Blphenotj-pi c Leukemia . ASC P Check Sample , 1991 ; H91-7 . Polycythemi aVeraEvohTu g into Acute Myeloi dLeukemia . ASC P Chec k Sample . 1991 ; H91-6 . Thromboii c Thrombocytopeni c Purpura . ASC P Chec k Path . 1990;AQ5036 . CiinicaU y Significant

Vinises : A

n Update . AMTEvcnts , 1989;4:83-89 . Th e Acute Abdomen : A Doctora l Thesis . Damascu s Universit y Press , 19S3 . Influenc e o f

Eiiolog> ' o f

Hea n Failur e o

n th e Prognosti c Significanc e o f HLA-Dr 3 afte

r Heart Transplantation : Evidenc e fo r Enhance dHumoral Iminunit>

- i n Idiopathi c Dilate dCardiomyopaihy . (Submitte dfo

r publicatio n i n th e America n Journal o f

Transplantation) . Abstract s Cardiovascula

r Death s i n Hear t Transplant

Recipients : Doe s tli e Rejectio n Pattern Matters ? The International Societ

y o f Heart an dLun g Transplantatio n 25 * Annual Meetin g an dScientifi c Sessions . Philadelphia , Apri

L 2005 . DN A Repai r Protein s a s Predictiv e Factor s fo r Lon g ter mSurvival i

n Patient s wit

h Glioblastom a Multifoim e Receivin g Post-operativ e Inadiaiio n andNitrosoureas , aPossibl e Rol e fo r DNA Mismatc h Repair , P53 , andERCC! : A Radiatio n Therap y Oncolog>

- Group Study . ASC O Meeting , Ne w Orleans , June , 2004 . Lon g Ter mSurvivor s wit

h Glioblastom aMultiforme (GBM ) Treate dwit h Irradiatio n an dNitrosourea s Hav e Highe r

Initial Expressio n o f

KJ-67 . ASC O Annual Meeting , New Orleans , June , 2004 . Expressio n o f

DN A Rjepai r Molecule s i s no t

aSignificant

Prognosti c Facto r

fo r Lon g Ter mSur^ivorawit

h Glioblastom aMultiforme (GBM ) Receivin g Irradiatio n andNitrosoureas . ASC O Annua l Meeting , Ne w Orleans , June , 2004 . Long-te mSurvrvoi s wit

h Glioblastom aMultifonn c Treate dwit h Irradiatio n andNitrosoure aHav e Higher Initial Expressio n o f

Ki-67 . ASC O Annual Meeting , Ne w Orleans , June , 2004 . Effcc u o f Tricho5tati n A o n Cel l Growt h an dth e Expressio n o f

Cel l Cycl e an dApopiosis-relate dFaaor s i n Platinum-resistan t

Ovarian Corcinom aCel l Lines . American Associatio n o f Cance r Research , TorontO

j Canada , April , 2003 .08/17/201 1 100 7 FA X 202493514 2 FA A - OM S ©023/02 3 n'ji: . 10 . .'U N r:M|-T/ i Kt(iULAKJf\ Y AFrAl^i S NO. 34 ; ? . 23/2 3

Pania l Aorti c Valv e Fusio n Relate dt o LVAD Suppor t Hear t Failure andCirculator

y Support Summi t Conference . July . 2002 . Ris k Facto r fo r Pcr^iste mo r

Recurren t

Steroid-Resistan t

Cardia c Allograf

t Rejection : I s Pre-transplan t Diagnosi s o f

Idiopathi c Dilat ^ Cardiomyopaili y aRis k Facto r Associate dWit

h Poo r Outcome' ' American Hear t Societ y Aimua l Meeting s May , 2001 . Po?t* r Pr^.sentatioD S Developmen t

o f a n ,'^5sa y fo r Detectio o o f

MPL W515 L an dK

Mutation s Usin g Invader

Plu s Reagait s i

n Periphera l Bloo dan dBon e Marro w Aspirates . Optima l Prerparatio n o f

Hematologi c Smears . Presente da t th e Pa n Pacitl c Lymphom aConference , Maui , Hawau , Jun e 2007 . Immunophenotyp e Associate dwit h Down' s Syndrom e Leukemi aan dTransien t Myeloproliferativ e Disorder . Prescnrc da t

th e Clinical AppUcation s o f Flo w Cvrometr

y Annual Meeting , Orlando , Florida , Nov . 2001 . Ris k Facto r fo r Persisten t

orKecunm t

Steroid-Resistan t

Cardiac Allograf

t Rejection : I s Pre-Lranspian t Diagnosi s o f

Idiopathi c Dilare dCardiom3'oparh y aRis k Faao r Associate dWit

h Poo r Outcome ? Presente d a t th e America

n Hear i Associatio n meetin g i n Anaheim , Ca , Kovember , 200 1 The Utilit y o f CD79 aa s aMarker

o f B-cel l Lineag e i n Flo w Cytometri c Evaluatio n o f Acut e Leukemia . Presente da

t th e Clinical Application s o f Plo w Cytometr

y Annual Meeting , Austin , Te.\as , Mov . 2000 . Professiona l Society Fellowship s an dMembership s International Academ

y o f ?atbolog> ' Unite dSlate s an dCanadian Academ y o f Patholog y Colleg e o f

American Pathologist s American Societ

y o f Hematolog y America n Societ y for Clinical Patholog y International Societ

y lo r Anabtica l Cjlolog) ' Ciinica J Cytometr

y Societ y Societj

- fo r Hematopaiholog y International Societ> ' fo

r Laboratory Hematolog y Ketterin g Alumn i Associatio n Reference s Reference s wil l b e provide dupo n reques t 3/2 0 U